Latest News

Credit: Arif Biswas | stock.adobe.com
Landmark Phase III Trial Results Show Blincyto Plus Chemotherapy Boosts Three-Year Survival in Pediatric Standard-Risk B-Cell ALL

December 9th 2024

The Phase III AALL1731 trial demonstrated that adding Blincyto (blinatumomab) to chemotherapy significantly improved three-year disease-free survival in pediatric patients with standard-risk B-cell acute lymphoblastic leukemia.

Ensuring Data Integrity with Artificial Intelligence
Ensuring Data Integrity with Artificial Intelligence

December 9th 2024

Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials

December 6th 2024

Credit: oz | stock.adobe.com
Phase III MOVe-NOW Trial to Evaluate New Lagevrio Formulation Targeting High-Risk COVID-19 Patients

December 6th 2024

Peer Exchange: Technology's Role in Achieving Greater DE&I in Clinical Trials
Peer Exchange: Technology's Role in Achieving Greater DE&I in Clinical Trials

December 6th 2024

Applied Clinical Trials November 2024

Check out the latest features and columns!

Check out the latest features and columns!

Conference Coverage

View All
Insights From the SCRS Global Site Solutions Summit
Insights From the SCRS Global Site Solutions Summit

November 1st 2024

4 Key Themes From Industry Conferences in 2024
4 Key Themes From Industry Conferences in 2024

October 25th 2024

2024 Veeva R&D and Quality Summit: Tina Bowdish Highlights the Importance of Site-Sponsor Relationships
2024 Veeva R&D and Quality Summit: Tina Bowdish Highlights the Importance of Site-Sponsor Relationships

October 16th 2024

DPHARM 2024: Developing AI/ML Models for Clinical Trials
DPHARM 2024: Developing AI/ML Models for Clinical Trials

September 23rd 2024

Latest Videos
Podcasts
© Alex from the Rock - © Alex from the Rock - stock.adobe.com

All News

© 2024 MJH Life Sciences

All rights reserved.